People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Other Health Care, Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HistoSonics, Inc. | — | Other Health Care | Series D+ | $308.2M | $1.0B | 2020 |
| Bluejay Therapeutics, Inc. | — | Pharma | Series D+ | $221.7M | $2.1B | 2022 |
| Goldfinch Bio, Inc. | — | Pharmaceuticals | Series C | $69.7M | $2.4B | 2020 |
Wen Chen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wen Chen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alon Lazarus | 1 | 7 |
| ABBIE CELNIKER | 1 | 6 |
| V. Kadir Kadhiresan | 1 | 5 |
| Linda Tufts | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| Jon Freeman | 1 | 5 |
| NEIL EXTER | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Kadir Kadhiresan | 1 | 4 |
| Nancy Hong | 1 | 4 |
| Michael Blue | 1 | 4 |
| Kyle Kuvalanka | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Dan Estes | 1 | 3 |
| Andrew Von Eschenbach | 1 | 3 |
| Anthony Johnson | 1 | 3 |
| William J. Rutter | 1 | 3 |
| Richard Eric Bosler | 1 | 2 |
| Akhil Tripathi | 1 | 2 |
| Tom Tefft | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.